Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
251.06
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,167
Open
251.06
Bid (Size)
251.30 (200)
Ask (Size)
252.30 (3,200)
Prev. Close
251.06
Today's Range
251.06 - 251.06
52wk Range
184.38 - 255.99
Shares Outstanding
N/A
Dividend Yield
2.76%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
July 01, 2026
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.03% on an annualized basis producing an average annual return of 16.59%. Currently, AbbVie has a market capitalization of...
Via
Benzinga
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From
Biotech Insider
Via
GlobeNewswire
Performance
YTD
+9.5%
+9.5%
1 Month
+17.9%
+17.9%
3 Month
+16.8%
+16.8%
6 Month
+9.9%
+9.9%
1 Year
+32.1%
+32.1%
More News
Read More
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
↗
June 30, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 No-Brainer Dividend Stocks to Buy Right Now
↗
June 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Inc (NYSE:ABBV) Breakout Setup Combines Strong Technical Rating with High-Quality Consolidation Entry
↗
June 17, 2026
Via
Chartmill
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
↗
June 29, 2026
Via
The Motley Fool
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
June 29, 2026
Via
StockStory
Topics
Retirement
Stocks
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
↗
June 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
Is AbbVie a Buy After Its Purchase of Apogee?
↗
June 25, 2026
Via
The Motley Fool
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
↗
June 24, 2026
Via
Benzinga
2 Value Stocks Worth Your Attention and 1 Facing Headwinds
June 24, 2026
Via
StockStory
3 Monster Stocks to Hold for the Next 10 Years
↗
June 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
Why AbbVie Stock Jumped Today
↗
June 22, 2026
Via
The Motley Fool
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?
↗
June 22, 2026
Via
The Motley Fool
Monday's session: top gainers and losers in the S&P500 index
↗
June 22, 2026
Via
Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
June 22, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Explore the top gainers and losers within the S&P500 index in today's session.
↗
June 22, 2026
Via
Chartmill
5 Dividend Stocks to Buy and Hold Forever
↗
June 22, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Excellent Dividend Stocks to Buy on the Dip
↗
June 22, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Profitable Stocks Worth Your Attention and 1 We Avoid
June 22, 2026
Via
StockStory
How Many Botox Units Do You Need: Forehead, Crow's Feet, and Frown Lines
June 18, 2026
Via
Press Release Distribution Service
3 High-Yield Dividend Stocks to Buy Hand Over Fist in June
↗
June 15, 2026
Via
The Motley Fool
Topics
Economy
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?
↗
June 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.
↗
June 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 251.06
When was AbbVie last traded?
The last trade of AbbVie was at 07/01/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today